Ne Rx Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NE RX PHARMA
NE RX PHARMA has five approved drugs.
Summary for Ne Rx Pharma
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Ne Rx Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ne Rx Pharma | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 217283-002 | Mar 6, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ne Rx Pharma | METOLAZONE | metolazone | TABLET;ORAL | 216216-003 | Oct 25, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ne Rx Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 217197-002 | May 9, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ne Rx Pharma | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 216786-001 | Feb 1, 2024 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
